Miscellaneous
The Food and Drug Administration panel of advisers rejected Pfizer’s proposal to the widespread distribution of booster shots. This influential panel of scientists agrees to administer vaccines for people over 65 and those with a significant risk of infection, but not for everybody. They claimed they are not needed for younger adults yet.